Skip to content
GLP-1 Savers
Menu
Ranked #340 · Watch List

Eve review

Eve is a women's-health-focused GLP-1 telehealth platform — distinctive positioning in a largely gender-neutral market — offering both compounded semaglutide.

By Grant Ashford, Founder & Pricing Editor

Est. first month

From $195/mo

Save ~86% vs brand-name

From $195/mo (compounded)

Get this deal Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Value Score.
Pricing to watch. The published figure is a single-tier rate, not a price that is guaranteed at every dose, and the price is not shown until after you complete an intake.

How much does Eve cost?

The price Eve publishes is From $195/mo (compounded). We flag this one to watch: confirm the ongoing rate with Eve before you count on it, because a low first month can step up afterward. That works out about 86% under our ~$1,349/mo brand-name cash reference.

Semaglutide
From $195/mo (compounded)
Tirzepatide
From $195/mo (compounded)
Coverage
Coverage not published
Brand-name
Yes

The Value Score card

Eve scored on our six published factors. See the methodology.

Lowest Real Price73/100
No Teaser-Rate Bait30/100
Nationwide Availability45/100
Both Molecules98/100
Easy Cancellation62/100
Reputation73/100

Why it's a deal

  • Genuinely women's-health-focused — fills a real gap among gender-neutral GLP-1 competitors
  • Both compounded and brand-name FDA-approved options (Wegovy/Ozempic/Mounjaro) on one platform — rare
  • Publishes the FDA compounded-medication disclaimer
  • Oral sublingual semaglutide offered alongside injectable

Read the fine print

  • Full states-served list not disclosed publicly
  • 503A pharmacy partner not named, and 503A vs 503B status not specified
  • Named medical director / clinical leadership not disclosed
  • Corporate legal entity not disclosed
  • Governing law / arbitration venue not stated

The bottom line

Best for: Shoppers who want women's-health GLP-1 with compounded or brand-name access. Eve is a women's-health-focused GLP-1 telehealth platform — distinctive positioning in a largely gender-neutral market — offering both compounded semaglutide.

Ranked #340 of 427 programs we track — see our #1 deal, CoreAge Rx, for comparison.

Compare with other deals

The programs scoring closest to Eve, out of 426 others we track.

Shopping Eve against a specific rival? We put it head to head with our top-scoring pick on CoreAge Rx vs Eve, and every program that undercuts or outscores it — starting with Whoosh Wellness, the closest match on score — is ranked on the Eve alternatives ranking.

More programs we track (24)

396 more are reviewed too — see every GLP-1 program we track, ranked.

Pricing and coverage on this page were read from Eve's own website on ; the Value Score is our editorial judgment per the methodology. “% vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on Eve's site. Not medical advice; see our disclosure.

See every program ranked by price →

← Back to all deals